The G12 family of G proteins as a reporter of thromboxane A 2 receptor activity

Molecular Pharmacology

Volumn 69, Issue 4, 2006, Pages 1433-1440

  Zhang, Li ^a   DiLizio, Cherisse ^a   Kim, David ^a   Smyth, Emer M ^a   Manning, David R ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); ISOPROSTANE 8 ISOPROSTAGLANDIN F2 ALPHA; PINANE THROMBOXANE A2; PROSTAGLANDIN F2 ALPHA DERIVATIVE; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG; 8 EPI PROSTAGLANDIN F2ALPHA; 8-EPI-PROSTAGLANDIN F2ALPHA; DRUG DERIVATIVE; GUANINE NUCLEOTIDE BINDING PROTEIN ALPHA SUBUNIT; HYDRAZINE DERIVATIVE; PROSTAGLANDIN F2 ALPHA;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; DRUG POTENCY; GENE ACTIVITY; HUMAN; HUMAN CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; ANIMAL; ARMYWORM; CELL LINE; METABOLISM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; RADIOASSAY;

ANIMALS; CELL LINE; DINOPROST; ELECTROPHORESIS, POLYACRYLAMIDE GEL; GTP-BINDING PROTEIN ALPHA SUBUNITS, G12-G13; HUMANS; HYDRAZINES; RADIOLIGAND ASSAY; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SPODOPTERA;

EID: 33645097713     PISSN: 0026895X     EISSN: 15210111     Source Type: Journal    
DOI: 10.1124/mol.105.019703     Document Type: Article

References (34)

1. 1A receptor in Sf9 cells. J Biol Chem 270:18691-18699.
2. 2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity. Eur J Pharmacol 485:317-327.
3. 2. Science (Wash DC) 296:539-541.
4. Dorn GW 2nd, Davis MG, and D'Angelo DD (1997) Structural determinants for agonist binding affinity to thromboxane/prostaglandin endoperoxide (TP) receptors: analysis of chimeric rat/human TP receptors. J Biol Chem 272:12399-12405.
5. Egan KM, Wang M, Lucitt MB, Zukas AM, Pure E, Lawson JA, and FitzGerald GA (2005) Cyclooxygenases, thromboxane and atherosclerosis: plaque destabilization by cyclooxygenase-2 inhibition combined with thromboxane receptor antagonism. Circulation 111:334-342.
6. Francois H, Athirakul K, Mao L, Rockman H, and Coffman TM (2004) Role for thromboxane receptors in angiotensin-II-induced hypertension. Hypertension 43:364-369.
7. 2-isoprostane receptors on rat vascular smooth muscle cells. Am J Physiol 264:C1619-C1624.
8. 2-isoprostane. Biochem Biophys Res Commun 195:507-515.
9. Janssen LJ (2001) Isoprostanes: an overview and putative roles in pulmonary pathophysiology. Am J Physiol 280:L1067-L1082.
10. 2α. J Pharmacol Exp Ther 281:957-964.
11. 2 and prostacyclin in the development of atherosclerosis in apoE-deficient mice. J Clin Investig 114:784-794.
12. Kozasa T and Gilman AG (1995) Purification of recombinant G proteins from Sf9 cells by hexahistidine tagging of associated subunits. J Biol Chem 270:1734-1741.
13. Miggin SM and Kinsella BT (1998) Expression and tissue distribution of the mRNAs encoding the human thromboxane A2 receptor (TP) α and β isoforms. Biochim Biophys Acta 1425:543-559.
14. Milligan G (2000) Insights into ligand pharmacology using receptor - G-protein fusion proteins. Trends Pharmacol Sci 21:24-28.
15. 13 is an essential mediator of platelet activation in hemostasis and thrombosis. Nat Med 9:1418-1422.
16. Montuschi P, Barnes PJ, and Roberts LJ (2004) Isoprostanes: markers and mediators of oxidative stress. FASEB J 18:1791-1800.
17. 2α, a potent agonist of the vascular thromboxane/endoperoxide receptor, is a platelet thromboxane/endoperoxide receptor antagonist. Prostaglandins 44:155-163.
18. 2 and thrombin receptors in human platelets. Proc Natl Acad Sci USA 91:504-508.
19. 2+ pathway in rabbit platelets. Br J Pharmacol 117:1095-1104.
20. 2α is not mediated by thromboxane receptor isoforms. J Biol Chem 271:14916-14924.
21. 2 receptor [published erratum appears in J Biol Chem 1995;270:7011]. J Biol Chem 269:19256-19261.
22. 12 family. Trends Pharmacol Sci 26:146-154.
23. Rudic RD, Brinster D, Cheng Y, Fries S, Song W-L, Austin SC, Coffman TM, and FitzGerald GA (2005) COX-2-derived prostacyclin modulates vascular remodeling. Circ Res 96:1240-1247.
24. q with Rho and its exchange factors. J Biol Chem 276:15445-15452.
25. Siefert R, Wenzel-Seifert K, and Kobilka BK (1999) GPCR-Gα fusion proteins: molecular analysis of receptor-G-protein coupling. Trends Pharmacol Sci 20:383-389.
26. 13. J Biol Chem 269:19796-19802.
27. Smith WL, DeWitt DL, and Garavito RM (2000) Cyclooxygenases: structural, cellular and molecular biology. Annu Rev Biochem 69:145-182.
28. i pathways integrated downstream of a single G protein-coupled sphingosine-1-phosphate receptor isoform. Mol Cell Biol 23:1534-1545.
29. Valentin, Field MC, and Tippins JR (2004) The mechanism of oxidative stress stabilization of the thromboxane receptor in COS-7 cells. J Biol Chem 279:8316-8324.
30. 2 receptor-dependent and -independent manner. Mol Pharmacol 63:1075-1081.
31. Wilson SJ, Roche AM, Kostetskaia E, and Smyth EM (2004) Dimerization of the human receptors for prostacyclin and thromboxane facilitates thromboxane receptor-mediated cAMP generation. J Biol Chem 279:53036-53047.
32. 12 families of heterotrimeric G proteins. J Biol Chem 274:27351-27358.
33. 35S]GTPγS binding. Methods Enzymol 344:3-14.
34. 13. J Biol Chem 276:38619-38627.